Update on rituximab

被引：39

作者：

Eisenberg, R ^{[1
]}

机构：

[1] Univ Penn, Philadelphia, PA 19104 USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷

关键词：

D O I：

10.1136/ard.2005.042648

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：55 / 57

页数：3

共 27 条

[21] Rituximab chimeric Anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:: Half of patients respond to a four-dose treatment program [J].

McLaughlin, P ;

Grillo-López, AJ ;

Link, BK ;

Levy, R ;

Czuczman, MS ;

Williams, ME ;

Heyman, MR ;

Bence-Bruckler, I ;

White, CA ;

Cabanillas, F ;

Jain, V ;

Ho, AD ;

Lister, J ;

Wey, K ;

Shen, D ;

Dallaire, BK .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2825-2833

[22] Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis [J].

Monson, NL ;

Cravens, PD ;

Frohman, EM ;

Hawker, K ;

Racke, MK .

ARCHIVES OF NEUROLOGY, 2005, 62 (02) :258-264

[23] Mice carrying a CD20 gene disruption [J].

O'Keefe, TL ;

Williams, GT ;

Davies, SL ;

Neuberger, MS .

IMMUNOGENETICS, 1998, 48 (02) :125-132

[24] CD20: A gene in search of a function [J].

Riley, LK ;

Sliwkowski, MX .

SEMINARS IN ONCOLOGY, 2000, 27 (06) :17-24

[25] Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis [J].

Schroder, AE ;

Greiner, A ;

Seyfert, C ;

Berek, C .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) :221-225

[26] T cell activation in rheumatoid synovium is B cell dependent [J].

Takemura, S ;

Klimiuk, PA ;

Braun, A ;

Goronzy, JJ ;

Weyand, CM .

JOURNAL OF IMMUNOLOGY, 2001, 167 (08) :4710-4718

[27] CD20 - A REGULATOR OF CELL-CYCLE PROGRESSION OF B-LYMPHOCYTES [J].

TEDDER, TE ;

ENGEL, P .

IMMUNOLOGY TODAY, 1994, 15 (09) :450-454

← 1 2 3 →